May/June

Debate Around Drug Cost Must Include Proven Value of Drug Therapies

May 16, 2019

Features

As we debate who should pay for health care and how, it is critical to make clear what we expect to get for those payments: high-quality, cost-effective care that improves patient outcomes—in other words, value.

Can Newly Proposed Rebate Rule Help With High Oncology Prescription Drug Costs?

May 16, 2019

Viewpoints: The Last Word

On February 6, 2019, the Department of Health and Human Services (HHS) proposed a rebate rule, Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees.